The Global Hematology Diagnostics Market is likely to derive growth from the increasing incidence of blood disorders. According to a report by Fortune Business Insights, titled “Hematology Diagnostics Market Size, Share and Global Trend By Type (Instruments, Consumables), By End User (Diagnostic Centers, Hospitals and Clinics, Academic and Research Institutions), and Geography Forecast till 2026,” the market will benefit from increasing product launches in the coming years.
“Some of the Main Key Players Covered in the Report”
- Beckman Coulter
- HORIBA, Ltd.
- Sysmex Corporation
- Instrumentation Laboratory, A Werfen Company
- Siemens Healthineers
- Hoffmann-La Roche Ltd.
- Bio-Rad Laboratories
- HemoCue AB
Hematology refers to disorders associated with blood and blood-forming organs. The severity of hematology disorders due to the high dependency of the human body on blood and blood cells has led to a growing emphasis on efficient treatment options. The increasing emphasis on research and development of new drugs and therapies will have a positive impact on the global hematology diagnostics market.
Browse Complete Report Details @ https://www.fortunebusinessinsights.com/industry-reports/hematology-diagnostics-market-100650
In addition to the severity of hematology disorders, their high prevalence will add to the demand for efficient diagnostic methods. According to the World Health Organization, around 40% of the total pregnant women suffer from a blood disorder ‘anemia’. Combined with the increasing incidence of blood disorders, the development of health infrastructures and increasing prevalence of ageing population, the global hematology diagnostics market will witness considerable growth in the coming years.
“Market to Benefit from the Launch of Several Enhanced Diagnostic Systems”
The increasing prevalence of hematology disorders has led to several product innovations and also created an increase in product launches in recent years. The market is likely to benefit from recent product launches and is set to derive growth from product innovations in the foreseeable future.
In 2018, Abbott announced the launch of its Alinity h-series Integrated Hematology System aimed at enhanced hematology analysis. Abbott’s latest received the CE mark in the same year and Fortune Business Insights predicts that this product will have a positive impact on the global market. Another notable product that caught the eyes of several investors was Horiba’s D-Dimer hematology reagent, aimed at the betterment of its hemostasis instruments.
The report encompasses several products similar to the latest products by Abbot and Horiba and gauges their impact on the global hematology diagnostics market.
“North America and Europe Among the Leading Regions in the Global Market”
The report includes segmentation of the global hematology diagnostics market based on several aspects such as product type, end user, and regional demographics. Among all regions, Fortune Business Insights predicts that the market will see comparatively high growth in North America and Europe. The increasing prevalence of blood disorders in these particular regions has favored growth in the aforementioned regional markets.
Additionally, several ongoing research and development (R&D) activities towards the development of advanced diagnostic methods will contribute to the growth of the hematology diagnostic market in North America as well as Europe. Having said that, Asia Pacific is likely to witness considerable growth in the coming years due to the enhanced healthcare systems in regions such as Japan and China.
Fortune Business Insights provides a comprehensive analysis of several companies that are operating in the market. Besides providing a brief review of their business strategies, Fortune Busines Insights focuses on the impact of these companies on the global market.
A few of the prominent companies that are currently operating in the global market include Beckman Coulter, Inc., Abbott, HORIBA, Ltd., Sysmex Corporation, Instrumentation Laboratory, Siemens AG, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., HemoCue, and Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
“More Trending Topics from Future Business Insights”